Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs

GLP-1 Receptor Agonists

New Studies Tie GLP‑1 Pathway to Small Hair‑Loss Risk and Show Rapid Rise in Off‑Label Use in Young Children

The results force urgent research and monitoring to define long‑term harms and to guide pediatric prescribing.

GLP‑1 Use Reaches 11% of U.S. Adults as New Evidence Spurs Policy and Safety Scrutiny

Half of Semaglutide Users Quit Within a Year as Higher Dose Trials Show Bigger Losses, More Side Effects

GLP-1 Weight-Loss Injections Show Hormonal and Neuroprotective Benefits

UK Regulator Probes Pancreatitis Cases Linked to GLP-1 Weight-Loss Drugs

Novo Nordisk Launches Wegovy Weight-Loss Drug in India